Prostate Cancer Patients–Negative Biopsy Controls Discrimination by Untargeted Metabolomics Analysis of Urine by LC-QTOF: Upstream Information on Other Omics

The existing clinical biomarkers for prostate cancer (PCa) diagnosis are far from ideal (e.g., the prostate specific antigen (PSA) serum level suffers from lack of specificity, providing frequent false positives leading to over-diagnosis). A key step in the search for minimum invasive tests to compl...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Peralbo, M. A., Gómez-Gómez, E., Calderón-Santiago, M., Carrasco-Valiente, J., Ruiz-García, J., Requena-Tapia, M. J., Luque de Castro, M. D., Priego-Capote, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133625/
https://www.ncbi.nlm.nih.gov/pubmed/27910903
http://dx.doi.org/10.1038/srep38243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133625/
https://www.ncbi.nlm.nih.gov/pubmed/27910903
http://dx.doi.org/10.1038/srep38243

Ejemplares similares